Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

AMERICAN FORENSIC TOXICOLOGY SERVICES LLC

NPI: 1417283623 · HUNTINGTON, NY 11743 · Clinical Medical Laboratory · NPI assigned 10/22/2009

$33.21M
Total Medicaid Paid
1,096,542
Total Claims
677,610
Beneficiaries
56
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialFREEMAN, SYLVIA (MGR OF CREDENTIALING/ENROLLMENT)
NPI Enumeration Date10/22/2009

Related Entities

Other providers sharing the same authorized official: FREEMAN, SYLVIA

ProviderCityStateTotal Paid
REGIONAL TOXICOLOGY SERVICES, LLC TACOMA WA $60.35M
SECON OF NEW ENGLAND LLC WORCESTER MA $8.88M
ROCKY MOUNTAIN TOX, LLC AURORA CO $236K
TECHNICAL RESOURCE MANAGEMENT LLC INDIANAPOLIS IN $119.72

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 300,684 $11.74M
2019 206,969 $5.15M
2020 148,898 $4.29M
2021 168,848 $4.98M
2022 119,922 $3.00M
2023 92,662 $2.00M
2024 58,559 $2.05M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 401,478 221,921 $14.94M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 304,883 174,510 $11.25M
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 53,559 36,884 $3.30M
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 45,163 25,628 $2.58M
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 3,650 2,596 $364K
80346 24,700 14,058 $80K
80348 19,510 15,166 $55K
80361 20,326 12,452 $53K
80365 18,817 12,262 $51K
80355 10,959 8,434 $32K
80358 12,811 8,918 $31K
80349 11,504 8,140 $31K
80354 10,682 8,287 $30K
80353 10,246 8,119 $27K
80357 8,087 6,965 $27K
80325 7,794 6,697 $25K
80356 7,406 6,260 $19K
80362 6,354 5,049 $19K
80359 7,306 6,057 $18K
80338 5,296 4,632 $18K
80360 9,953 7,001 $18K
80323 6,850 3,725 $17K
83992 4,901 4,057 $17K
80333 4,293 3,770 $16K
80372 6,650 6,053 $15K
81025 2,618 1,424 $14K
80373 6,126 5,238 $14K
80366 4,876 4,159 $14K
80337 4,116 3,628 $13K
80364 6,067 5,417 $13K
80368 7,068 5,901 $11K
82570 2,617 1,614 $11K
80369 5,961 5,294 $10K
80371 4,752 4,018 $10K
83986 1,885 1,288 $10K
80324 3,429 2,683 $10K
80367 2,924 2,513 $7K
80321 3,062 2,433 $6K
80320 1,315 1,172 $5K
80345 2,270 1,993 $4K
80332 2,092 1,751 $4K
80363 1,280 1,074 $4K
80336 1,232 860 $3K
80352 1,240 853 $3K
80305 718 477 $2K
80342 1,810 1,465 $2K
80171 171 155 $1K
80374 563 408 $1K
84311 934 749 $684.86
36415 Collection of venous blood by venipuncture 859 775 $389.11
80343 403 380 $385.61
81003 820 665 $327.87
80375 1,498 1,024 $180.00
80339 272 226 $149.14
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 349 300 $23.58
80341 37 32 $0.00